Introduction
Sudden cardiac death due to ventricular tachyarrhythmias remains the major cause of mortality in the world. 1 There is a well-established link of aberrant intracellular Ca 2þ homeostasis with enhanced propensity of the heart to arrhythmias in hypertrophy, heart failure, myocardial infarct, and aging. [2] [3] [4] Pro-arrhythmic spontaneous Ca 2þ release from the sarcoplasmic reticulum (SR) in these conditions, accompanied by excessive production of reactive oxygen species (ROS), is largely ascribed to abnormally high activity of oxidized ryanodine receptors (RyRs), the SR Ca 2þ release channels. [4] [5] [6] [7] [8] During recent years mitochondria, located in close proximity to RyR clusters in cardiac cells, gained recognition as a major source of ROS in diseased, aged, or stressed hearts. 4, [9] [10] [11] [12] Furthermore, targeted scavenging of mitochondrial ROS was proven to attenuate spontaneous Ca 2þ release most probably via restoration of RyR redox state. 4, 9, 13 Small conductance Ca 2þ -activated potassium channels (SK) mediate the feedback between intracellular Ca 2þ dynamics and membrane repolarization in excitable cells. [14] [15] [16] The SK channel family consists of three members: SK1 (KCa2.1, KCNN1), SK2 (KCa2.2, KCNN2), and SK3 (KCa2.3, KCNN3) that exhibit high degree of homology and conductance of 5-20 pS. The tetrameric SK channels are voltage independent and their gating is predominantly controlled by intracellular [Ca 2þ ] in the submicromolar range conferred by constitutively bound calmodulin. In ventricular myocytes from healthy hearts plasmalemmal SK (pSK) channels are functionally dormant. However, enhanced SK expression and increased sensitivity to Ca 2þ (from 500 to 200 nmol/L) was shown in myocytes from failing hearts and from myocardial infarct border zones. [17] [18] [19] [20] [21] [22] We recently demonstrated that RyR-mediated SR Ca 2þ release is both necessary and sufficient for activation of pSK channels. 23 Furthermore we showed that enhanced expression of SK channels plays an anti-arrhythmic role by countering the depolarizing force of the Na þ /Ca 2þ exchanger (NCX) during spontaneous Ca 2þ release. Despite attenuating arrhythmia trigger in the form of Ca 2þ -dependent early or delayed afterdepolarizations (EADs and DADs, respectively), 23, 24 disease-associated SK upregulation was also shown to promote a substrate for arrhythmia because of action potential shortening and non-uniform tissue expression of the channels. [18] [19] [20] [21] It should be noted that previous studies extensively used SK blockers or transgenic mouse models to assess the role of SK channels in arrhythmogenesis. 14, 15 However, anti-arrhythmic potential of pharmacological enhancement of endogenous SK channels remains unexplored. Importantly, in addition to plasmalemmal localization, the presence of functional SKs was demonstrated in the inner mitochondria membrane (mSK). Activation of mSK was found to prevent glutamateinduced oxytosis and mitochondrial dysfunction in a neuronal cell line. 25 Subsequently, mSK channels were discovered in ventricular cardiomyocytes (CMs), where their pharmacological activation protects against ischaemic cardiac injury. 26 In both cases, activation of mSK channels preserves mitochondrial function and reduces production of ROS in cells under stress. Previous studies of cardiac mitochondrial K þ channels such as mK ATP and mBK Ca have been mostly focused on their 'pre-conditioning' protection over ischaemic injury, [27] [28] [29] 
Methods
The tissue, cellular, subcellular, and molecular effects of pharmacological manipulation with SK channels were studied at the organ level and in isolated adult rat ventricular myocytes from sham hearts and hearts with hypertrophy induced by TAB four weeks after procedure. In this wellestablished commercially available model (Charles River Labs), ligation of the ascending aorta results in pressure overload inducing development of cardiac hypertrophy and enhanced arrhythmogenesis in 4 weeks. 30, 31 We studied whole hearts using dual voltage-Ca 2þ optical mapping. At the cellular level, cytosolic Ca 2þ changes were monitored using confocal microscopy, and membrane potential was recorded with the whole cell patch-clamp technique using myocytes isolated from TAB hearts. Changes in levels of RNA, protein expression, and protein oxidation were studied using standard approaches. An expanded Methods section can be found in the Supplementary material online.
Results

Ex vivo dual voltage and Ca 2þ optical mapping
To gain insight into the role of SK channels in arrhythmogenesis at the organ level we performed ex vivo whole heart studies using simultaneous membrane potential (Vm) and Ca 2þ mapping with the voltage sensitive dye RH278 and the Ca 2þ indicator Rhod-2. 32 Exposure to the b-adrenergic agonist isoproterenol (ISO, 50 nmol/L) induced frequent premature ventricular complexes (PVCs, red arrows) and VT/VF in seven out of seven TAB hearts and one out of eight Sham hearts. Importantly, incubation of TAB hearts with the membrane permeable SK enhancer NS309 (2 lmol/L, 20 min) 33 completely abolished PVCs and ventricular arrhythmia induced by ISO, as seen from ECG recordings in Figure 1A . TAB rats showed electrical remodelling resulting in prolongation of APD ( Figure 1B) in agreement with earlier studies. 30, 31 Incubation with NS309
did not shorten APD in TAB rats, while subsequent application of the membrane impermeable SK peptide inhibitor apamin (10 nmol/ L) 15, 17, 18, 20 in the presence of NS309 and ISO prolonged APD. These data suggest that SK channels are present in the plasma membrane of ventricular myocytes from TAB rats and the maximal contribution of SK channels to APD is achieved, such that NS309 does not produce any further effect on APD. Figure 1C demonstrates representative activation maps recorded in Sham and TAB rat hearts exposed to ISO. The activation maps of VT/VF showed conduction blocks and reentry formation in addition to frequent PVCs. Membrane permeable SK enhancer NS309 alleviates wavebreaks and VT/VF without detectable effects on conduction velocity ( Figure 1C and D). Subsequent application of apamin did not promote VF despite prolongation of APD ( Figure 1B ) and presence of PVCs ( Figure 1A , red arrow in the bottom trace).
To study potential effects of SK modulators on spontaneous SR Ca 2þ release we used burst stimulation followed by pause ( Figure 1E ). Figure 1E , F and G). Consequent application of apamin produced moderate increases in rate and amplitude of spontaneous Ca 2þ release ( Figure 1E , F and G) most likely because of an increased Ca 2þ influx from the extracellular milieu through L-type Ca 2þ channels due to APD prolongation. These data suggest that enhancement of SK activity in TAB rat hearts attenuates ventricular arrhythmias primarily due to its stabilizing effect on Ca 2þ release.
Effects of SK channel modulators in hypertrophic rat ventricular CMs
To extend our studies to the cellular level we performed whole cell patch clamp experiments and confocal Ca 2þ imaging ( Figure 2) . We found that 10 min. exposure of the SK2-and SK3-specific enhancer, CyPPA (10 lmol/L), 35 significantly decreased the ISO-induced incidence of EADs, DADs, and underlying spontaneous Ca 2þ waves (SCWs) in TAB myocytes. Similar stabilizing effect on Ca 2þ waves was achieved in a separate set of experiments by exposing TAB myocytes to 10 lmol/L NS309 for 10 min, while 10 lmol/L GW542473X (specific SK1 enhancer) 36 showed no effect (Supplementary material online, Figure   S2 ). Conversely, the SK inhibitor UCL-1684 (1 lmol/L) 37 promoted
SCWs and afterdepolarizations ( Figure 2 ). In addition, UCL-1684 significantly prolonged APD80 in TAB cells (Supplementary material online, Figure S3 ). 
Expression and distribution of SK isoforms in rat ventricular myocytes
Despite a high degree of homology, three known SK channels isoforms (SK1-3) exhibit differential expression patterns in different tissues and in 26 Using quantitative real time PCR (RT-qPCR) and Western blot analysis we assessed intracellular distribution and possible changes in expression of SK isoforms in myocytes from TAB hearts. Our RT-qPCR results confirm that all three isoforms are expressed in rat ventricular myocytes (Supplementary mate rial online, Figure S1A ). Hypertrophy induced by TAB did not change the mRNA levels of SK1 and SK2, while SK3 levels showed two-fold increase (n = 4, P < 0.05, Student's t-test). To assess specificity of anti-SK antibodies we constructed shRNAs to inhibit expression of SK1-3.
Freshly isolated rat ventricular myocytes were infected with adenoviruses (MOI 100) carrying shRNA constructs and after 48 h in primary culture cell lysates were subjected to SDS PAGE ( Figure 3A) . SK1 was identified as 66 kDa band (theoretical molecular weight 59.2 kDa), while SK2 and SK3 were running close to 100 kDa which is higher than their predicted molecular weights (62.2 and 81.4 kDa, respectively). Bioinformatic sequence analysis demonstrates that SK1 and SK2 but not SK3 have N-terminal mitochondria targeting sequences (Supplementary material online, Figure S4 ; also see MitoProt: http://ihg.gsf.de/ihg/mito prot.html). 39 In line with this prediction, our next experiments using differential centrifugation of cell lysates from isolated ventricular myocytes established SK3 as the major isoform localized to surface membrane, while SK1 was found predominantly in the mitochondrial fraction, and SK2 was present in both ( Figure 3B ). Cytochrome C (Cyt C) and mitochondrial Ca 2þ uniporter (MCU) were used as markers for mitochondria fraction. Pan-cadherin and a1c and a2 subunits of plasmalemmal Ca 2þ channels were used as markers of membrane fraction. Analysis of protein expression levels demonstrated that SK3 and pSK2 are significantly reduced in TAB membranes when normalized to pan-cadherin ( Figure 3B and C). SK1 and mitochondrial SK2 (mSK2) normalized to MCU showed no changes in TABs in comparison to Shams in mitochondrial fraction. Western blot analysis using total cell lysate samples from Sham and TAB ventricular myocytes showed no change in the protein levels of SK1, and SK3, while SK2 was 50% higher in TABs ( Figure 3D and E).
Modulators of SK channels affect mitochondrial membrane potential in ventricular CMs
We Importantly, neither UCL-1684 (1 lmol/L), nor SK activator CyPPA (10 lmol/L) had dramatic effects on mitochondrial Ca 2þ uptake
(Supplementary material online, Figure S6A and B). These data imply that 25, 29 We were unable to detect statistically significant changes in DWm upon application of SK activators in concentrations near reported EC 50 s (less or 10 lmol/ L). 33, 35, 36 However, application of 100 lmol/L CyPPA (selective to SK2
and SK3) resulted in 40% depolarization of DWm as measured by TMRE fluorescence in permeabilized cells ( Figure 4C and D) . Depolarization of IMM evoked by 25 lmol/L of CyPPA or NS309 was fully reversible by consequent application of membrane permeable SK inhibitor UCL-1684 (1 lmol/L, Supplementary material online, Figure  S7C and 1D) but not by application of membrane impermeable apamin (100 nmol/L, Supplementary material online, Figure S7A and B). Taken together, the effects of SK enhancers are most consistent with the activation of mSK channels, allowing K þ influx and depolarization of DWm. [27] [28] [29] Importantly, incubation of permeabilized myocytes with the SK1-specific SK activator GW542573X (100 lmol/L) failed to produce changes in DWm. The latter suggests that the presence of SK1 in mitochondrial fraction (see Figure 3B ) does not result in proper retainment of the functional channel in the IMM, which leaves SK2 as the only functional SK subtype out of three targeted to mitochondria. For a mechanistic link between mSK channel activation and mitochondrial function in TAB rats, we measured the effect of the membrane-permeable SK inhibitor UCL-1684 (1 lmol/L) on DWm in permeabilized Sham and TAB CMs. As shown in Figure 5A and B, UCL-1684 resulted in a small (10%) but significant hyperpolarization of DWm in myocytes from TAB rats, while no effect was detected in Sham cells. This observation is consistent with mSK channels being activated at baseline in diseased hearts, causing a small depolarization of DWm which is reversible by SK inhibition. Importantly, data presented in Figure 5C and D suggest that mSK channels were not maximally activated in TAB cells because both NS309 (selective to SK1, SK2, and SK3) and CyPPA (selective to SK2 and SK3) at high concentrations were able to evoke DWm depolarization. Interestingly, the SK1-selective activator GW542573X failed to produce any changes in DWm in TAB cells ( Figure 5C and D) consistent with no effect on SCWs (see Supplementary material online, Figure S2 ).
Effects of SK modulators on mitochondrial ROS production and RyR hyperactivity in hypertrophic CMs
Excessive ROS production by mitochondria is a hallmark of hypertrophy, heart failure or aging; conditions that are often accompanied by proarrhythmic disturbances in Ca 2þ handling. Our data demonstrate that increased ROS production is likely responsible for the increased frequency of RyR-mediated SCWs in CMs from TAB rats, as direct scavenging of mitochondria derived ROS with mito-TEMPO (mitochondria specific-scavenger, 10 lmol/L, 10 min.) 4,13 also inhibits the proarrhythmic SCWs (Supplementary material online, Figure S8 ). The monobromobimane (mBB) fluorescence assay shows that incubation of hypertrophied CMs with CyPPA or NS309 reduces thiol-oxidation of a protein band with MW similar to RyRs ( Figure 6A and B) . Experiments using Figure S10 ) consistent with our hypothesis that mSK enhancement eliminates SCWs by reducing ROS production. Furthermore, experiments using the mitochondria-specific ROS indicator MitoSOX demonstrated that inhibition of SK channels with UCL-1684 increased ROS production, while enhancers NS309 and CyPPA reduced it in freshly isolated TAB CMs ( Figure 6C) . To assess the direct effects of SK activation on RyR-mediated SR Ca 2þ leak, we performed measurements of Ca 2þ sparks in myocytes permeabilized with saponin to eliminate any potential contribution of effects caused by plasma membrane SKs that can confound interpretation of the results. As shown in Figure 7 , Ca 2þ spark frequency is increased, while SR Ca 2þ content measured using rapid application of 20 mmol/L caffeine is decreased in myocytes from TAB rats vs. Shams. Ten-minute pre-incubation with 10 lmol/L CyPPA or NS309 resulted in higher SR Ca 2þ load in TAB myocytes and in case of NS309, which is more potent SK enhancer 35 significantly reduced Ca 2þ spark frequency.
It is well known that RyR activity is controlled by [Ca 2þ ] not only at its cytosolic activation sites, but at luminal sites as well. 40 Figure 2 , Supplementary material online, Figure S2 ) and thereby propensity to Ca 2þ -dependent arrhythmia.
Discussion
Recently SK channels gained recognition as an attractive new target for treatment of malignant cardiac arrhythmias. [14] [15] [16] Previous reports were focused on delineating the role of aberrant expression/function of pSK channels and the potential cardioprotective role of mSK channels is only beginning to emerge. 26 In this work, using rat model of pressureoverload-induced hypertrophy, 30, 31 we provide the first evidence that mSK channels modulators can influence SR Ca 2þ release via regulation of mitochondrial ROS production, which determines oxidative state and activity of RyRs in diseased hearts.
SK modulation and ventricular arrhythmia
Previous studies using bee-venom peptide apamin, a specific SK inhibitor, demonstrated that inhibition of SK channels in rabbit hearts with heart failure induced by rapid pacing can attenuate arrhythmia via prolongation of APD and reducing heterogeneity, thus limiting reentry. 16, 18, 19, 20 However, experiments in single cells from human and canine failing hearts demonstrated that apamin application not only further prolongs already long APD caused by electrical remodelling, but also induces profound instabilities in repolarization suggesting an anti-arrhythmic role of SKs. 17 Furthermore, we recently showed in rat myocytes with adenovirus-mediated overexpression of SK2 that pro-arrhythmic spontaneous Ca 2þ release effectively induces repolarizing SK current which attenuate NCX-driven afterdepolarizations. 23 Accordingly, in failing rabbit hearts, apamin exacerbated EADs associated with disturbances in Ca 2þ cycling. 24 Taken together, results of these studies imply that in conditions accompanied with aberrant Ca 2þ handling, enhancement rather than inhibition of SK channels must play a protective role by limiting Ca 2þ -dependent triggering events in the form of EADs and DADs.
Indeed, our experiments in whole hearts and single cells demonstrate beneficial anti-arrhythmic effects of SK enhancers and pro-arrhythmic effects of SK inhibitors ( Figures 1 and 2 and Supplementary material online, Figure S2 ). SK inhibitors prolonged APD in TABs providing an evidence of the presence of functional SK channels in plasma membrane of TAB CMs ( Figure 1B , Supplementary material online, Figure S3) . Remarkably, SK enhancers NS309 and CyPPA (which increase SK activity by sensitizing channels to Ca 2þ ) 35 failed to shorten APD both in whole hearts ( Figure 1B ) and in isolated CMs (Supplementary material online, Figure S3A ). This implies that pSK channels in TABs are already hypersensitive to Ca 2þ , which is similar to human 18 and rabbit HF. 
Expression and distribution of SK channels in ventricular myocytes
In addition to enhanced sensitivity of pSKs to Ca 2þ , increased expression levels of the channels were demonstrated in humans and several animal models of heart failure and myocardial infarct. [16] [17] [18] [19] [20] [21] [22] Our results using RTqPCR demonstrate that SK1 and SK2 mRNA levels are unchanged and SK3 mRNA levels are two-fold higher in isolated CMs from TABs than Shams. However, Western blot analysis shows no change in SK3 levels in whole CMs lysates ( Figure 3D and E). One possibility why SK3 protein levels remain unchanged in TAB CMs at increased mRNA levels is translation interference by microRNAs. To test this possibility we assessed the expression levels of muscle-specific microRNA 499 (miR-499), showed to target SK3. 42 We found that the levels of miR-499 are significantly higher in TABs vs. Shams (Supplementary material online, Figure  S1B ). SK1 protein levels were unchanged in CMs which is consistent with RT-qPCR results, while SK2 was moderately 50% higher in TABs vs Shams despite no change in mRNA levels. Our results markedly differ from reported two-to four-fold upregulation of SK2 and SK3 protein levels in tissues from rat, 43 human and canine failing hearts. 15, 17 This discrepancy can be attributed to the existence of SK channels in cell types other than myocytes that are present in cardiac tissue and also undergo disease-associated remodelling. For example, SK channels are likely present in fibroblasts 44 and endothelial cells 45 and can contribute to substantial increase in expression levels detected in ventricular tissues from HF patients. Moreover, our experiments with fractionation of CMs demonstrated significant reduction of pSK2 and SK3 ( Figure 3B and D) . Ren et al. 46 demonstrated that phosphorylation of SK2 by protein kinase A at three C-terminal serines leads to the channel removal from the plasma 
membrane. It is possible that in conditions when blood levels of catecholamines are increased like in HF, plasmalemmal localization of SK2 and structurally similar SK3 channels is diminished rather than increased as previously thought.
Our further experiments with CMs fractionation confirmed presence of SK channels in mitochondria of ventricular myocytes as described by Stowe et al. 26 However, this study did not provide definite answer which SK isoform resides in the IMM in CMs. We demonstrate that SK1 and SK2 subtypes are present in the mitochondrial fraction in rat CMs, while SK3 is restricted to the plasmalemma ( Figure 3B) . These results are in agreement with bioinformatics prediction, which suggested that SK1 and SK2 but not SK3 have N-terminal mitochondria-targeting sequences (MitoProt
39
: http://ihg.gsf.de/ihg/mitoprot.html, 26 January 2017, date last accessed; Supplementary material online, Figure S4 ). SK1 and SK2 localized in mitochondria show no change in expression levels in TABs ( Figure  3C) . Importantly, the bioinformatics programme also predicts that SK2 exhibits much higher probability of mitochondria targeting than SK1 (0.90 vs. 0.17, respectively). In line with this, our data show lack of effect of SK1-specific activator GW542573X on DWm ( Figures 4C, D, 5C and D) and SCWs (Supplementary material online, Figure S2 ). Although we cannot completely rule out potential role of SK1, our results establish SK2 as the major SK isoform residing in the inner mitochondrial membrane.
SK channels and mitochondrial ROS
Cardioprotection mediated by mitochondrial K ATP and BK Ca 2þ -activated channels is well established, while the cardioprotective potential of mSK channels is only beginning to emerge. BK and K ATP channel openers are known to reduce damaging ROS production by mitochondria (under stress conditions), decrease arrhythmic potential, and improve overall cardiac function after ischaemia-reperfusion or hydroxyl radical-induced stunning in failing hearts. 14, [27] [28] [29] 47 Recently Stowe et al. 26 demonstrated that pharmacological pre-conditioning using SK enhancers resulted in dramatically improved function of guinea pig hearts subjected to ischaemia-reperfusion. This improvement was linked to normalized mitochondria bioenergetics accompanied by reduced levels of superoxide production. Our pharmacological analysis confirms presence of functional mSKs in ventricular myocytes responsive to changes in [Ca  2þ ] within the physiological range, determined in experiments assessing DWm (Figure 4) . Furthermore, increased activity of mSK ( Figure 5A and B) may be an adaptive response to preserve mitochondria function as inhibition of mSK channels in hypertrophic myocytes results in increased mito-ROS production measured with MitoSOX ( Figure 6C) . Importantly, pharmacologic enhancement of mSK channels in TAB CMs reduced mito-ROS rendering them similar to control CMs ( Figure 6C ). It should be noted that activation of mito-K þ channels during pre-conditioning was well established to increase rather than decrease mito-ROS emission by accelerating electron flux along the respiratory chain. In line with this, our experiments revealed that treatment of rat myocytes from healthy hearts with 10 lmol/L CyPPA increased rate of ROS production (not shown). Interestingly, our experiments showed that neither SK enhancer nor SK inhibitor can dramatically affect mitochondrial Ca 2þ uptake in TAB CMs (Supplementary material online, Figure S6 ), thus SK-mediated changes in mito-ROS production are likely not dependent on changes in mito-Ca 2þ homeostasis. Apparently, the exact mechanisms of mSK-mediated protection in cells from diseased hearts, 
where ROS levels are already high, are yet to be determined and their delineation will require extensive efforts in the future.
SK channels and RyR-mediated Ca 2þ release
Overactive RyRs play a central role in arrhythmias associated with hypertrophy, heart failure, MI, and aging. [4] [5] [6] [7] Excessive activity of RyRs in these conditions is routinely attributed to posttranslational modifications including phosphorylation at RyR's CaMKII and PKA sites and oxidation of reactive cysteines. 8, 40, 41 Reducing agents were shown to produce stabilizing effects on RyRs resulting in attenuation of SR Ca 2þ leak, pro-arrhythmic SCWs and Ca 2þ alternans in many experimental settings. [5] [6] [7] [8] 13 We recently demonstrated that incubation of ventricular myocytes derived from old rabbit hearts with mitochondria-specific ROS scavenger mito-TEMPO normalizes RyR redox state and thereby SR Ca 2þ release, 4 which corroborates the theory of a tight control of RyR function by mitochondria mediated by ROS. 4, 10, 11, 13 Our data demonstrate that pharmacological enhancement of SKs reverses oxidation of RyRs in myocytes from hypertrophic hearts via normalization of ROS production by mitochondria ( Figure 6 , Supplementary material online, Figure S10 ), which results in stabilization of RyR-mediated Ca 2þ release (Figure 7) , attenuation of proarrhythmic SCWs at the single cell level (Figure 2 , Supplementary material online, Figure S2 ) and rescue of Ca 2þ homeostasis in the whole heart experiments ( Figure 1) . Importantly, while blockade of pSK channels produces anti-arrhythmic effects in certain conditions by reducing arrhythmic substrate, our data imply that usage of membrane-permeable SK inhibitors may affect mitochondrial function thus promoting Ca 2þ -dependent triggers for arrhythmia.
Limitations
Usage of pharmacological modulators of ion channels and small peptides can raise concerns of their specificity and potential off-target effects. To address these concerns we performed experiments in rat myocytes infected with adenoviral constructs carrying rSK2 and maintained in primary culture for 48 h. SK2 overexpression significantly reduced the number of SCWs (Supplementary material online, Figure S9 ) and mito-ROS measured with MitoSOX (SK: 842 ± 99 a.u., n = 4; Control: 1338 ± 80 a.u., n = 5, P < 0.05, Student's t-test), similar to the effects of pharmacological activators of SK2 in freshly isolated TAB cells. The other limitation is that we cannot completely rule out a possible role of pSK channels in the regulation of mitochondrial function and thereby Ca 2þ release.
Finally, presented data does not provide the exact mechanism by which mSKs can regulate mitochondrial ROS production, which is the subject of future research.
Conclusions
Our results suggest that functional upregulation of SK channels in hypertrophic hearts serve protective, albeit incomplete, roles against Ca 2þ -dependent arrhythmia via two independent mechanisms ( Figure 8 
